Presentation is loading. Please wait.

Presentation is loading. Please wait.

Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,

Published byHerta Schmid Modified over 5 years ago

Similar presentations

Presentation on theme: "Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,"— Presentation transcript:

1 Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert, PhD  Journal of Allergy and Clinical Immunology  Volume 108, Issue 4, Pages S107-S110 (October 2001) DOI: /mai Copyright © 2001 Mosby, Inc. Terms and Conditions

2 Fig. 1 Ribbon diagram of the three-dimensional structure of toxic shock syndrome toxin-1 (TSST-1). TSST-1 is a two-domain molecule, designated A (β grasp fold) and B (OB fold). The domain for TSST-1 binding to MHC II molecules is listed as the low affinity interaction site; the listed high affinity site is not present in TSST-1 but is present in a number of other superantigens, including streptococcal pyrogenic exotoxin C and staphylococcal enterotoxin A. The site on TSST-1 for binding to TCRVβ is indicated as the top back of the toxin. For other superantigens the TCRVβ site is on the top front of the toxin, for example staphylococcal enterotoxins B and C and streptococcal pyrogenic exotoxin A. Journal of Allergy and Clinical Immunology  , S107-S110DOI: ( /mai ) Copyright © 2001 Mosby, Inc. Terms and Conditions

Download ppt "Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,"

Similar presentations

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Shin-Ichi Nishikawa, MD, PhD 

Shin-Ichi Nishikawa, MD, PhD 
Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis  Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,

Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis  Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,
Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,

Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,

Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Rosa Codina, PhD, Richard F. Lockey, MD 

Rosa Codina, PhD, Richard F. Lockey, MD 
Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma 

Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma 
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: Multifactorial states of clinical importance  Tomoshige Kino, MD, PhD, George P.

Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: Multifactorial states of clinical importance  Tomoshige Kino, MD, PhD, George P.
Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,

Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Practice Notes from the AAAI

Practice Notes from the AAAI
Rosaura Casas, MSc, Malin F

Rosaura Casas, MSc, Malin F
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
Elephantiasis nostras: A case report

Elephantiasis nostras: A case report

Similar presentations

Ads by Google